Literature DB >> 7666506

Tyrosine 807 of the v-Fms oncogene product controls cell morphology and association with p120RasGAP.

S Trouliaris1, U Smola, J H Chang, S J Parsons, H Niemann, T Tamura.   

Abstract

Expression of the v-fms oncogene of feline sarcoma virus in fibroblasts causes surface exposure of an activated receptor tyrosine kinase, v-Fms, that is autophosphorylated at multiple sites within its cytoplasmic domain. Cellular proteins interacting with this part of v-Fms modulate the mitogenic activity and morphology of the cells. We show here that the tyrosine residue in position 807 (Y-807) of the v-Fms molecule constitutes a major autophosphorylation site. The replacement of this residue by phenylalanine (Y807F mutation) allowed us to functionally dissect v-Fms-specific mitogenic and morphogenic cascades. Cells expressing the mutant v-Fms molecule resembled wild-type (wt) v-Fms-transformed (wt-v-Fms) cells in terms of [3H]thymidine uptake rates and activation of the Ras/Raf-1 mitogenic cascade. Such cells showed, however, a flat morphology and contained intact actin cables and fibronectin network. Our studies indicate that the v-Fms molecule controls cell morphology by a cascade that involves a direct interaction with p120RasGAP and p190RhoGAP: (i) in contrast to wt v-Fms molecules, the Y807F v-Fms protein failed to associate with and phosphorylate p120RasGAP; (ii) tight complexes between p120RasGAP and p190RhoGAP as well as detectable RhoGAP activity were present exclusively in wt-v-Fms cells; and (iii) p190RhoGAP was dispersed throughout the cytoplasm of wt-v-Fms cells, whereas its distribution was restricted to perinuclear regions of cells expressing the mutant v-Fms gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7666506      PMCID: PMC189497     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Influence of tyrosine residues Y705 and Y807 on the transforming potency of the v-fms oncogene product of feline sarcoma virus.

Authors:  S Trouliaris; A Hadwiger-Fangmeier; M Heimann; T Tamura
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

2.  Activation of the feline c-fms proto-oncogene: multiple alterations are required to generate a fully transformed phenotype.

Authors:  J Woolford; A McAuliffe; L R Rohrschneider
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

3.  A PDGF receptor domain essential for mitogenesis but not for many other responses to PDGF.

Authors:  J A Escobedo; L T Williams
Journal:  Nature       Date:  1988-09-01       Impact factor: 49.962

4.  Identification of distinct cytoplasmic targets for ras/R-ras and rho regulatory proteins.

Authors:  M D Garrett; A J Self; C van Oers; A Hall
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

Review 5.  The protein kinase family: conserved features and deduced phylogeny of the catalytic domains.

Authors:  S K Hanks; A M Quinn; T Hunter
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

6.  Nucleotide sequence of the feline retroviral oncogene v-fms shows unexpected homology with oncogenes encoding tyrosine-specific protein kinases.

Authors:  A Hampe; M Gobet; C J Sherr; F Galibert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

7.  A glioma-derived PDGF A chain homodimer has different functional activities from a PDGF AB heterodimer purified from human platelets.

Authors:  M Nistér; A Hammacher; K Mellström; A Siegbahn; L Rönnstrand; B Westermark; C H Heldin
Journal:  Cell       Date:  1988-03-25       Impact factor: 41.582

8.  Isolation of a transformation-defective mutant of the McDonough strain of feline sarcoma virus exhibiting tyrosine kinase activity in vitro but not in vivo.

Authors:  T Tamura; D Hennig; M Grell; H Niemann; B Boschek
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

9.  gp140v-fms molecules expressed at the surface of cells transformed by the McDonough strain of feline sarcoma virus are phosphorylated in tyrosine and serine.

Authors:  T Tamura; E Simon; H Niemann; G T Snoek; H Bauer
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

10.  A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential.

Authors:  M F Roussel; J R Downing; C W Rettenmier; C J Sherr
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

View more
  3 in total

1.  Sequential activation of phoshatidylinositol 3-kinase and phospholipase C-gamma2 by the M-CSF receptor is necessary for differentiation signaling.

Authors:  R P Bourette; G M Myles; J L Choi; L R Rohrschneider
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

2.  Phosphotyrosine (p-Tyr)-dependent and -independent mechanisms of p190 RhoGAP-p120 RasGAP interaction: Tyr 1105 of p190, a substrate for c-Src, is the sole p-Tyr mediator of complex formation.

Authors:  R W Roof; M D Haskell; B D Dukes; N Sherman; M Kinter; S J Parsons
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

3.  RhoA is required for cortical retraction and rigidity during mitotic cell rounding.

Authors:  Amy Shaub Maddox; Keith Burridge
Journal:  J Cell Biol       Date:  2003-01-21       Impact factor: 10.539

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.